SERA Insider Trading

Insider Ownership Percentage: 15.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,668,928.82

Sera Prognostics Insider Trading History Chart

This chart shows the insider buying and selling history at Sera Prognostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$358soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Sera Prognostics Share Price & Price History

Current Price: $3.25
Price Change: Price Increase of +0.14 (4.50%)
As of 04/11/2025 05:00 PM ET

This chart shows the closing price history over time for SERA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$3.25Closing price on 04/11/25:

SEC Filings (Institutional Ownership Changes) for Sera Prognostics (NASDAQ:SERA)

54.64% of Sera Prognostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SERA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$24kbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$5M$0$5MTotal InflowsTotal Outflows
Sera Prognostics logo
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Read More on Sera Prognostics

Today's Range

Now: $3.25
Low: $3.00
High: $3.38

50 Day Range

MA: $3.97
Low: $3.11
High: $5.04

52 Week Range

Now: $3.25
Low: $2.99
High: $12.36

Volume

47,989 shs

Average Volume

131,807 shs

Market Capitalization

$122.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of Sera Prognostics?

Sera Prognostics' top insider shareholders include:
  1. Zhenya Lindgardt (CEO)
  2. Austin Aerts (CFO)
  3. Paul Kearney (Insider)
  4. John J Boniface (Insider)
  5. Benjamin Jackson (General Counsel)
  6. Robert Gardner Harrison (Insider)
  7. Mansoor Raza Mirza (Director)
  8. Joshua Phillips (Director)
Learn More about top insider investors at Sera Prognostics.

Who are the major institutional investors of Sera Prognostics?

Sera Prognostics' top institutional shareholders include:
  1. Sanders Morris Harris LLC — 0.25%
  2. Rhumbline Advisers — 0.11%
Learn More about top institutional investors of Sera Prognostics stock.

Which major investors are buying Sera Prognostics stock?

In the previous quarter, SERA stock was acquired by institutional investors including:
  1. Rhumbline Advisers
  2. Sanders Morris Harris LLC